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Purpose: To assess the feasibility of a method based on microwave spectrometry to detect structural
distortions of metallic stents in open air conditions and envisage the prospects of this approach toward
possible medical applicability for the evaluation of implanted stents.
Methods: Microwave absorbance spectra between 2.0 and 18.0 GHz were acquired in open air for the
characterization of a set of commercial stents using a specifically design setup. Rotating each sample
over 360◦, 2D absorbance diagrams were generated as a function of frequency and rotation angle.
To check our approach for detecting changes in stent length (fracture) and diameter (recoil), two
specific tests were performed in open air. Finally, with a few adjustments, this same system provides
2D absorbance diagrams of stents immersed in a water-based phantom, this time over a bandwidth
ranging from 0.2 to 1.8 GHz.
Results: The authors show that metallic stents exhibit characteristic resonant frequencies in their
microwave absorbance spectra in open air which depend on their length and, as a result, may reflect
the occurrence of structural distortions. These resonances can be understood considering that such
devices behave like dipole antennas in terms of microwave scattering. From fracture tests, the authors
infer that microwave spectrometry provides signs of presence of Type I to Type IV stent fractures
and allows in particular a quantitative evaluation of Type III and Type IV fractures. Recoil tests
show that microwave spectrometry seems able to provide some quantitative assessment of diametrical
shrinkage, but only if it involves longitudinal shortening. Finally, the authors observe that the resonant
frequencies of stents placed inside the phantom shift down with respect to the corresponding open
air frequencies, as it should be expected considering the increase of dielectric permittivity from air to
water.
Conclusions: The evaluation of stent resonant frequencies provided by microwave spectrometry al-
lows detection and some quantitative assessment of stent fracture and recoil in open air conditions.
Resonances of stents immersed in water can be also detected and their characteristic frequencies are
in good agreement with theoretical estimates. Although these are promising results, further verifica-
tion in a more relevant phantom is required in order to foresee the real potential of this approach.
© 2014 American Association of Physicists in Medicine. [http://dx.doi.org/10.1118/1.4866881]
Key words: microwaves, stents, coronary artery disease, stent fracture, stent recoil
1. INTRODUCTION
A stent1, 2 is a medical prosthetic device shaped as a small
cylindrical tube with wire mesh walls, which is used to
revascularize atherosclerotic stenosed blood vessels. The first
generation of conventional, bare-metal stents was developed
in the mid-1980s.3 Despite their obvious advantages, in-
stent neointimal hyperplasia4–6 occurred in some cases. This
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phenomenon, also known as in-stent restenosis, was directly
linked to stent implantation and resulted in restenosis rates of
20%–30%.7 It was the attempt to minimize this problem, and
thereby reduce rates of repeated revascularization, that ulti-
mately lead to the development of drug-eluting stents.8 The
dramatic reduction in restenosis rates seen with the use of
this second generation as compared with the first one9–13 has
been the major driving force behind the exponential growth
of percutaneous coronary interventions as a treatment for pa-
tients with coronary artery disease. However, even with such
improvements, patients with coronary stents require chronic
medication and monitoring in order to prevent restenosis and
deterioration of the stent structural integrity.
In particular, physicians have studied the contributing fac-
tors and the clinical effects of stent fracture and stent recoil
in veins, coronary, and noncoronary arteries. Even if frac-
ture does not necessarily involve clinical sequelae, it repre-
sents a risk factor for restenosis, target lesion revasculariza-
tion, and other complications such as thrombosis, myocar-
dial infarction, and even sudden cardiac death.14–26 Exten-
sive studies quantifying the true incidence of stent fracture
continue to be lacking. Reported values range from 0.84%
(Ref. 27) to 65.4% (Ref. 28), although most of the avail-
able literature gives numbers below 8%. Some authors have
explicitly pointed out the lack of routine methods of moni-
toring or diagnosing stent fractures29 as well as the impor-
tance of detecting this phenomenon before the onset of re-
lated symptoms.25 Conversely, stent recoil has been much less
studied, but in any case its presence has been linked with un-
satisfactory revascularization and therefore with an increased
risk of adverse events.30–34 A few studies give incidence val-
ues from 1.6% to 6.9% and state that recoil is a significant
phenomenon that should be further explored.33, 34
For all these reasons considerable effort has been made
to improve stenting outcome. On the one hand, research has
been carried out to improve the design of stents. Promising
examples are biodegradable stents35 or devices allowing
wireless monitoring of pressure and blood flow.36, 37 Manu-
facturing methods based on microelectrodischarge machining
have also been suggested.38 On the other hand, work is
being conducted for the optimization of medical imaging
techniques aiming to produce real-time high-quality images
with minimal damage to the patient. These include nonin-
vasive techniques such as magnetic resonance39 and duplex
ultrasound,40 as well as invasive methods such as x-ray
angiography,41 intravascular ultrasound,42 intravascular pho-
toacoustic imaging,43 and optical coherence tomography.44
In spite of the obvious clinical benefits, these techniques
require justification of potential patient collateral damages,
such as impact of invasive procedures or ionizing radiation
dose. Microwave-based techniques have the advantage of
being nonionizing and noninvasive, and that is why they are
particularly suitable to develop new medical applications.45
We assess the feasibility of a method based upon mi-
crowave spectrometry (MWS) to detect structural distortions
of metallic stents. We show here that such devices exhibit
characteristic resonant frequencies in their microwave ab-
sorbance spectra which reflect the occurrence of changes in
stent length (fracture) or diameter (recoil), at least in open air
conditions. These resonant frequencies are also detected when
the stents are immersed in water and their values are in good
agreement with theoretical estimates. Further verification in a
more physiologically relevant phantom is required in order to
evaluate MWS as a possible new medical tool to improve the
monitoring of patients with implanted metallic stents.
2. EXPERIMENTAL METHODS
The experimental methods developed present three sepa-
rate stages. In the first part, we used MWS to characterize a
set of stents with the aim of achieving a global understanding
of the fundamental processes involved in the interaction of
microwaves with such devices. In the second part, only a few
stents with controlled structural distortions were tested for the
purpose of checking the capabilities of MWS to detect stent
fracture and recoil. Finally, in order to foresee the medical ap-
plicability of MWS, the study conducted in the first part was
reproduced, but this time using a more reliable environment
such as a water-based phantom.
2.A. Samples
We performed this study on 75 coronary stents of six dif-
ferent models from a single brand (see Table I). All of them
were fabricated by Medtronic Inc. using a 0.091-mm-thick
round wire of an alloy composed by Ni, Co, Cr, and Mo (35%,
32%, 20%, and 10%, respectively) and other elements like Fe,
Ti, Mn, Si, and C in ratios lesser than 1%.46–50 For each model
the manufacturer provides a range of nominal lengths, nom,
and nominal diameters, dnom. The nominal sizes of a given
stent are reached expanding the balloon catheter51 in which
it is mounted up to a certain value of nominal inflation pres-
sure, pnom, provided by the manufacturer in its commercial
kit. All pressures were achieved and measured by means of a
compatible inflation device.52 Five models present an archi-
tecture composed by a certain number of modular elements
(see microphotograph53 in Fig. 1). These modules are shaped
as sinusoidal 7-pointed crowns for dnom = 2.25–2.75 mm and
10-pointed crowns for dnom = 3.00–4.50 mm. The remaining
model is a single wire bent into a continuous sinusoidal archi-
tecture. In both cases the structure is reinforced by helicoidal
laser-fused welding patterns.
TABLE I. Type, architecture, and number of stents measured for the six mod-
els investigated: Driver Sprint (MDS), Integrity (MI), Driver (MD), Micro-
Driver (MMD), Endeavor Sprint (MES), and Endeavor Resolute (MER).
Model Type Architecture Stents
MDS Bare-metal Modular 31
MI Bare-metal Continuous 6
MD Bare-metal Modular 3
MMD Bare-metal Modular 3
MES Zotarolimus-eluting Modular 29
MER Zotarolimus-eluting Modular 3
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FIG. 1. Microphotograph of a MMD bare-metal stent (nom = 8.00 mm and
dnom = 2.75 mm) expanded up to pnom = 0.91 ± 0.05 MPa. This stent is
composed by seven modular elements shaped as 7-pointed sinusoidal crowns
held together by means of a single-helix welding pattern.
2.B. Setups
The stents were characterized by measuring their mi-
crowave absorbance spectrum using a specifically designed
system. Figure 2(a) shows a sketch of the MWS setup used
in open air conditions (Setup#1). To carry out the character-
izations a pair of microwave antennas with a 2.0–18.0 GHz
spectral range54 was connected to a two-port vector network
analyzer55 via coaxial feed lines.56 Measurements were per-
formed in a symmetrical configuration in which the center of
the stent was placed at the midpoint of the line joining the
antennas (optical axis), which were set at a constant sepa-
FIG. 2. (a) Sketch of the experimental setup for the microwave characteri-
zation of stents in open air conditions (Setup#1). The inset shows a detail of
the geometrical configuration. (b) Sketch of the phantom for the microwave
characterization of stents in water (Setup#2).
ration of 16.0 cm. The stents were positioned with the aid
of a handmade expanded polystyrene sample holder mounted
on a unipolar stepping motor,57 which was connected to a
single-board microcontroller58 through a home-built circuit.
This motorized sample holder allows rotation of the stent lon-
gitudinal axis (stent axis) an azimuthal angle ϕ around a ver-
tical axis that is perpendicular to the optical axis [see the inset
in Fig. 2(a)]. The microcontroller and the network analyzer
were connected to a computer, and the whole system was con-
trolled by means of a homemade program.59 This setup pro-
vides the transmission coefficient between the two ports of the
network analyzer as a function of frequency, S(f), from which
the absorbance spectrum can be calculated as
A(f ) = 10 log
(
Sref(f )
S(f )
)
. (1)
Here, Sref(f) denotes the reference transmission coefficient ac-
quired as a function of frequency without any stent placed
on the sample holder. Both S(f) and Sref(f) are the average
of one hundred measurements of each magnitude. For every
stent subsequent absorbance spectra were obtained in steps
of 1.8◦ over a 360.0◦ rotation around the vertical axis. All
the spectra collected this way for different azimuthal angles
are presented in a single absorbance diagram, A(f, ϕ), using
graphing and data analysis software.60
Figure 2(b) shows a sketch of the phantom used to char-
acterize the stents in a tissuelike environment (Setup#2).
It was built as a poly(methyl methacrylate) box (20 × 10
× 9 cm3) entirely filled with distilled water. Now the anten-
nas were 19.7 cm apart and were embedded in the two farthest
opposite faces of the box. In this configuration, the nominal
spectral range of the antennas shifts down with respect to the
range in open air and becomes around 0.2–1.8 GHz due to
the higher permittivity of water.61 The samples were placed
using a slightly modified version of the same rotating sam-
ple holder. This time, the stents were threaded through using
a 0.30-mm-thick nylon filament, and were suspended from
above at the center of the optical axis. As a result, an A(f, ϕ)
diagram was obtained for each stent characterized. Data pro-
cessing and any other system component are identical to those
explained for the characterization in open air.
2.C. Microwave resonance in open air
The A(f, ϕ) diagrams in open air were acquired for the full
set of stents using Setup#1 as described in Subsection 2.B.
All the stents were expanded using their catheters. After com-
pleting the expansion and the subsequent A(f, ϕ) acquisition,
the real length, , and the real diameter, d, of each stent were
recorded using a digital caliper.62 The final value of each mag-
nitude was the average of 12 measurements. The resonant fre-
quencies of every stent were obtained applying peak analysis
tools60 to the corresponding A(f, ϕ) diagram. To analyze the
dependence of such frequencies on the size of the stents, we
focused on a subset of 31 [MDS (Ref. 46)] plus 29 [MES
(Ref. 49)] samples (see Table II). These two models were se-
lected since they present the widest range of nominal sizes
(nom, dnom) among those available for this study.
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TABLE II. Set of commercial available sizes for the MDS bare-metal stent
and the MES Zotarolimus-eluting stent. Horizontal and vertical numbers in-
dicate, respectively, nominal length (nom) and nominal diameter (dnom), both
in millimeters. Solid circles (•) denote the 29 MDS plus 31 MES stents for
which the first two resonant frequencies were determined from absorbance
diagrams acquired in open air. The three asterisked samples (•*) were dam-
aged in fracture tests and could not be characterized in the subsequent phan-
tom tests. Open circles (◦) indicate stents that were not available for analysis
in this study.
(mm) nom 8.00 9.00 12.00 14.00 15.00 18.00 24.00 30.00
dnom MDS
2.25 • • • ◦ ◦ ◦
2.50 • •• • • • ◦
2.75 ◦ • • • •* ◦
3.00 • ◦ ◦ • ◦ ◦
3.50 • • • • ◦ •
4.00 • ◦ • • • •
4.50 • • • • • •
(mm) nom 8.00 9.00 12.00 14.00 15.00 18.00 24.00 30.00
dnom MES
2.25 • • • ◦ • •
2.50 ◦ • • • • •*
2.75 ◦ • ◦ ◦ • ◦
3.00 • • • • • •
3.50 • • • • • •
4.00 ◦ • • • • •*
2.D. Fracture tests
We performed fracture tests on two MES stents49 (nom
= 30.00 mm for both, dnom = 2.75 and 4.00 mm, respectively)
and one MDS stent46 (nom = 24.00 mm, dnom = 2.75 mm)
, which were chosen among the subset of MES and MDS
stents mentioned in Subsection 2.C. To illustrate the results
we have selected the last one, which was originally expanded
up to pnom = 0.91 ± 0.05 MPa. This stent has a modular ar-
chitecture that is composed by twenty 7-pointed crowns held
together by means of a single-helix welding pattern [dark dots
in Fig. 3(a)] supported by four extra welds at the ends of
the stent [light dots in Fig. 3(a)]. The stent was submitted to
a series of four cuts using a customized precision plier and
a hand lens. The cutting sequence described below was de-
vised to make the stent go gradually through four of the five
stages currently accepted by medical doctors to grade stent
fractures.28, 63 Cut 1 was carried out on the strut close to the
weld between crowns #11 and #12 [see small dotted circle in
Fig. 3(b)]. As a result the stent presented a single strut frac-
ture (Type I). Cut 2 was executed on the strut near the weld
that holds together crowns #5 and #6 [see small dotted circle
in Fig. 3(c)]. Hence the stent presented multiple strut frac-
tures (Type II). Cut 3 was performed again on crown #12,
in the strut just beneath the one where Cut 1 had been done.
This resulted in a complete transverse linear rupture (Type III
fracture) that separated the stent in two segments (labeled, re-
spectively, AB and C) [see Fig. 3(d)]. In a similar manner,
Cut 4 was applied on crown #6 in segment AB. Thus the stent
presented two complete transverse linear fractures (Type IV)
that split it in three segments (labeled, respectively, A, B, and
FIG. 3. (a) Planar representation of the modular architecture of a MDS bare-
metal stent (nom = 24.00 mm and dnom = 2.75 mm) expanded up to pnom
= 0.91 ± 0.05 MPa. [(b)–(e)] Sequence of four cuts applied to make the stent
go through Types I, II, III, and IV fracture grades, respectively. [(f) and (g)]
Microphotographs of the regions where Cut 2 and Cut 4, and Cut 1 and Cut
3 were, respectively, performed.
C) [see Fig. 3(e)]. Microphotographs in Fig. 3 detail the fi-
nal look of the regions on which cuts were made. Figure 3(f)
shows the region of Cut 2 and Cut 4, while Fig. 3(g) depicts
the region of Cut 1 and Cut 3. After each cut just described,
 and d were measured, and A(f, ϕ) diagrams were recorded.
The gap between the segments obtained after Cut 3 and Cut
4 [see Figs. 3(d) and 3(e), respectively] was set at 1 mm be-
fore the absorbance diagram was acquired for each set of seg-
ments. Identical results were obtained with 1, 2, 5, and 10 mm
gaps, for the stent shown in Fig. 3 and for the two MES stents
mentioned at the beginning of this subsection.
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2.E. Recoil tests
We performed recoil test on two MER stents50 (nom
= 15.00 mm, dnom = 3.00 mm; nom = 12.00 mm, dnom
= 4.00 mm), and two MI stents47 (nom = 26.00 mm for
both, dnom = 2.50 and 2.75 mm, respectively). To exem-
plify the results we have picked the last one, whose architec-
ture comprises a single wire bent into a continuous sinusoid.
The stent was submitted to a stepwise reverse recoil proce-
dure that consisted of a smooth augmentation of d achieved
by means of a progressive raise of p using its balloon catheter.
Although this goes the way opposite to natural recoil, in
which the stent diameter is reduced, we followed this proce-
dure for practical reasons: the balloon catheter is devised to be
used to inflate (not to collapse) the stent, and this makes the
diameter increase in a uniform way along the whole length of
the stent. At each stage, p, d, and  were measured and the
corresponding A(f, ϕ) diagram was acquired. To quantify the
recoil degree we define the following parameter as a function
of d:
r(d) = dM − d
dM − dm , (2)
where dM and dm are the maximum and minimum values for
the stent deployment diameter. We chose the diameter at pm
= 0.00 MPa (no pressure applied, that is when the stent
was just unpacked from its commercial kit) as dm = 1.14
± 0.05 mm, and the diameter reached overexpanding the stent
up to pM = 1.42 ± 0.05 MPa as dM = 3.29 ± 0.02 mm. In
this respect, the recoil degree shall be maximum (r = 1) for a
completely deflated stent (p = pm) and shall be minimum (r
= 0) for a stent expanded to the maximum pressure value (p
= pM) applied in the recoil test. The pM value for this stent is
higher than its corresponding nominal inflation pressure, pnom
= 0.91 ± 0.05 MPa, but in any case is within the safety range
given by the manufacturer.50
2.F. Microwave resonance in a water phantom
The A(f, ϕ) diagrams of 30 [MDS (Ref. 46)] plus 27 [MES
(Ref. 49)] stents (see Table II) immersed in the phantom pre-
viously described in Subsection 2.B (Setup#2) were acquired.
This was the same subset of stents characterized in open air,
except for the three stents that were damaged in fracture tests.
The corresponding resonant frequencies were recorded fol-
lowing a procedure analogous to the one previously described
in Subsection 2.C and were compared with the values ex-
pected from theoretical predictions.
3. RESULTS
3.A. Microwave resonance in open air
To highlight the resonances present in a typical A(f, ϕ) di-
agram we have chosen a MI stent,47 with nom = 26.00 mm
and dnom = 2.50 mm. This stent was expanded up to 2.23
± 0.05 MPa of inflation pressure, p, using the correspond-
ing balloon catheter. Figure 4(a) shows such A(f, ϕ) diagram.
Each horizontal line (or isoangular profile) in this graph rep-
resents the absorbance spectrum for a given azimuthal angle,
A(f), while each vertical line (or isofrequencial profile) rep-
resents the absorbance angular pattern for a given frequency,
A(ϕ). The isoangular projections show several discrete reso-
nant frequencies [see peaks at f1 = 2.55 ± 0.17 GHz, f2 = 4.87
± 0.17 GHz, and f3 = 7.00 ± 0.17 GHz in Fig. 4(b), where
A(f) spectra are shown for ϕ = 180◦ and ϕ = 243◦], each one
having characteristic A(ϕ) patterns in its corresponding isofre-
quencial projection [see Fig. 4(c)]. Such patterns are better
identified when A(ϕ) is plotted in polar form, as in Fig. 4(d).
FIG. 4. (a) A(f, ϕ) diagram acquired in open air for a MI bare-metal stent (dnom = 2.50 mm and nom = 26.00 mm) expanded up to p = 2.23 ± 0.05 MPa.
(b) Isoangular projections of A(f, ϕ) at ϕ = 180◦ (solid line) and ϕ = 243◦ (dashed line). (c) Isofrequencial projections of A(f, ϕ) at f1 = 2.55 ± 0.17 GHz (solid
line), f2 = 4.87 ± 0.17 GHz (dashed line), and f3 = 7.00 ± 0.17 GHz (dotted line). (d) Same isofrequencial projections represented in polar form.
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The first order, f1, shows a bilobular A(ϕ) pattern with peaks
occurring when the stent axis is perpendicular to the optical
axis. The second order, f2, shows a tetralobular A(ϕ) pattern,
with four peaks located around 40◦, 140◦, 220◦, and 320◦.
Higher resonances show more complex A(ϕ) dependences,
like hexalobular patterns for the third order, f3. We can thus
determine the order of a given resonance just inspecting its
corresponding A(ϕ) pattern. All the stents characterized in the
present work show exactly these same features. Although up
to sixth order resonances were identified in some isoangular
profiles, the monitoring of f1 is enough to illustrate our next
results.
Figure 5 shows f1 as a function of  for several dnom val-
ues, for the selected subset (see Table II) of 31 MDS stents
[Fig. 5(a)] and 29 MES stents [Fig. 5(b)]. All these stents were
expanded up to pnom = 0.91 ± 0.05 MPa using their catheters.
Although a well-defined dependence of f1 on the stent diame-
ter was not found, f1 seems to follow a 1/ behavior [interested
readers can refer to the supplementary material64 for extra
figures showing the dependences for f1(d) and f2(), in which
the same 1/ behavior can be observed for f2()].
3.B. Fracture tests
The results for the fracture test performed on the MDS
stent with nom = 24.00 mm and dnom = 2.75 mm, expanded
up to pnom = 0.91 ± 0.05 MPa, are shown in Fig. 6 (Type I
and Type II stages) and Fig. 7 (Type III and Type IV stages).
Table III summarizes the data retrieved from this test. Figures
6(a)–6(c) present the evolution of the A(f, ϕ) diagrams
from the intact stent to a Type II fractured stent. Beside the
diagrams, the planar representation of the stent geometrical
architecture in Figs. 6(d)–6(f) describes the cut sequence
applied. The resonant frequencies and the angular patterns
present in all diagrams are consistent with the properties
reported in Subsection 3.A. Figures 7(a) and 7(d) present,
respectively, the same A(f, ϕ) diagram and planar represen-
tation of the unaltered stent shown in Figs. 6(a) and 6(d),
while Figs. 7(b) and 7(c) represent, respectively, the A(f, ϕ)
diagrams for Type III [Fig. 7(e)] and Type IV [Fig. 7(f)]
fractures performed on this stent.
3.C. Recoil tests
A selection of steps for the recoil test performed on the MI
stent with nom = 26.00 mm and dnom = 2.75 mm is shown
in Fig. 8. Figure 8(a) presents the A(f, ϕ) diagram for the
stent without recoil, while Figs. 8(b)–8(e) do the same for
four increasing recoil degrees, from r = 0.053 ± 0.013 to
r = 0.288 ± 0.012. Notice how both f1 and f2 shift up pro-
gressively from Fig. 8(a) to Fig. 8(e), because as r increases,
and so the stent diameter narrows, its length also shortens, and
this is finally reflected as a rise of the resonant frequencies in
A(f, ϕ). Figure 9 highlights this frequency upshift for the en-
tire recoil test by plotting both f1 and f2 as a function of the
recoil degree, r.
FIG. 5. Measured first order resonant frequencies as a function of  for
several dnom values of the 31 MDS bare-metal stents (a) and the 29 MES
Zotarolimus-eluting stents (b) investigated in open air. Solid lines are the
least squares fits performed on each f1() data set using Eq. (4).
3.D. Microwave resonance in a water phantom
To illustrate the resonances present in a typical A(f, ϕ) di-
agram of a stent immersed in water, we have chosen a MES
stent49 with nom = 14.00 mm and dnom = 2.25 mm. This
stent was expanded up to pnom = 0.91 ± 0.05 MPa using
the corresponding balloon catheter. Figure 10 shows such
A(f, ϕ) diagram. The structures appearing around 0.25 and
0.29 GHz should be considered experimental artifacts coming
from resonances generated by the phantom box, since they
present no angular dependence and are common to all mea-
sured stents. Beside these artifacts, the A(f, ϕ) diagram shows
a characteristic bilobular structure that should be ascribed to a
true stent resonant frequency (f ′1 = 0.479 ± 0.007 GHz). All
stents characterized inside the phantom exhibit well-defined
resonances similar to the one chosen to illustrate this result.
Figure 11 shows the first resonant frequency measured in wa-
ter (f ′1) as a function of the first resonant frequency measured
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FIG. 6. (a) A(f, ϕ) diagram acquired in open air for a MDS bare-metal stent (nom = 24.00 mm and dnom = 2.75 mm) expanded up to pnom = 0.91
± 0.05 MPa. [(b) and (c)] Same diagrams after creating Type I and Type II fractures, respectively. (d) Planar representation of the original, unaltered stent.
[(e) and (f)] Cutting sequence performed to gradually bring the intact stent to a Type I and Type II fractured stent, respectively.
in air (f1) for the full set of 30 MDS plus 27 MES stents tested
in water.
4. DISCUSSION
4.A. Microwave resonance in open air
The shapes of the A(ϕ) experimental curves in Fig. 4(d)
closely resemble gain patterns of a center-feed half-wave
dipole antenna.65 This fact suggests that the microwave scat-
tering of stents is similar to that produced by such devices.
Chow et al. have evaluated the use of stents as antennas for
implantable wireless medical applications,66 which reinforces
this hypothesis. The microwave electromagnetic field couples
here to the dipole antenna conductive structure and induces a
standing electric current along it. As a consequence, the scat-
tering is enhanced at resonant frequencies given by67
fn(L) = nc2L√rμr , (3)
where r and μr are, respectively, the relative permittivity
and relative permeability of the dipole antenna surrounding
medium, c is the speed of light in vacuum, L is the length of
the antenna, and n is the resonance mode. Recently, Daschner
et al. have explained this phenomenon in the analogous con-
text of transmission line resonators.68
The following least squares fit60 was performed on the f1()
data set obtained for each dnom value:
f1() = A

+ B, (4)
where A and B are the fitting parameters. Figures 5(a) and 5(b)
represent these fits and the corresponding results are sum-
marized in Table IV. Despite not being able to give an in-
terpretation of B beyond its pure empirical sense, the results
suggest that the resonant frequencies in a stent of a certain
length are lower than those corresponding to a dipole antenna
of the same length. This means that metallic stents of length
 should behave akin to dipole antennas of length L = a in
terms of microwave scattering, where a = nc/2A√rμr is a
scaling factor that can be obtained from the fit. The presence
of a scaling factor greater than 1 (see a values in Table IV)
should be considered reasonable because of the characteristic
folded structure of coronary stents.
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FIG. 7. (a) A(f, ϕ) diagram acquired in open air for a MDS bare-metal stent (nom = 24.00 mm and dnom = 2.75 mm) expanded up to pnom = 0.91 ± 0.05 MPa.
[(b) and (c)] Same diagrams after creating Type III and Type IV fractures, respectively. (d) Planar representation of the original, unaltered stent. [(e) and (f)]
Cutting sequence performed to gradually bring the stent from Type II to Type III and Type IV fractures, respectively.
Due to the intricate anatomy of coronary arteries, it is ap-
propriate to discuss how the A(f, ϕ) diagrams should reshape
if we would measure stents presenting smooth bendings in
their geometries. In this case, the values of fn should remain
mostly unchanged because these frequencies depend mainly
TABLE III. Summary of the data obtained from the fracture test presented in
Figs. 6 and 7. From left to right, columns indicate cut number, segment label,
first resonant frequency (f1), stent length measured using a digital caliper (),
and stent length determined from least squares fit performed on MWS data
using Eq. (4) (MWS).
f1  MWS
Cut Segment (GHz) (mm) (mm)
0 ABC 2.58 ± 0.15 24.91 ± 0.03 24 ± 2
1 ABC 2.27 ± 0.10 24.72 ± 0.04 28 ± 3
2 ABC 2.13 ± 0.10 24.66 ± 0.04 30 ± 3
3 AB 3.08 ± 0.12 14.40 ± 0.03 19.4 ± 1.4
C 4.53 ± 0.19 11.17 ± 0.03 12.5 ± 0.8
4 A 7.3 ± 0.3 06.64 ± 0.02 07.5 ± 0.4
B 5.7 ± 0.2 07.93 ± 0.05 09.7 ± 0.6
C 4.6 ± 0.2 11.17 ± 0.03 12.4 ± 0.8
on the overall length of the stent, and only scarcely on its
shape. In contrast, the A(ϕ) patterns could experience major
changes at the resonances. For a perfectly straight resonator,
the scattering will be maximum (minimum) when its axis is
parallel (perpendicular) to the electric component of the in-
cident microwave electromagnetic field.65, 67 For a bent res-
onator the scattering should decrease (increase) with respect
to this maximum (minimum) value, because the projection of
the electric component onto its length is reduced (increased)
in relation to the electric component parallel (perpendicular)
to a straight resonator. As a result, the A(ϕ) diagrams would
soften their dependence on ϕ and therefore the lobes shown
in Fig. 4(d) should tend gradually to become isotropic circular
patterns.
4.B. Fracture tests
Figure 6 shows that Type I and Type II fractures result in
a downshift of f1 with respect to the value for the unaltered
stent (see the corresponding numbers in Table III). According
to Eq. (3), one might think that this decrease could be due to
an eventual increase of  caused by mechanical stress during
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FIG. 8. (a) A(f, ϕ) diagram acquired in open air for a MI bare-metal
stent (nom = 26.00 mm and dnom = 2.75 mm) expanded up to p = 1.42
± 0.05 MPa. At this stage there is no recoil, r = 0.000 ± 0.015. [(b)–(e)]
A(f, ϕ) diagrams for increasing recoil degrees: from top to bottom, r = 0.053
± 0.013, r = 0.133 ± 0.015, r = 0.214 ± 0.011, and r = 0.288 ± 0.012. For
each stage, the real length (), the real diameter (d), and the inflation pressure
(p) applied to the stent are shown.
FIG. 9. First and second resonant frequencies, f1 and f2, of a MI bare-metal
stent (nom = 26.00 mm and dnom = 2.75 mm) as a function of the recoil
degree, r, reached by expanding the stent following a series of increasing
values of the inflation pressure, p.
FIG. 10. A(f, ϕ) diagram of a MES drug-eluting stent (nom = 14.00 mm
and dnom = 2.25 mm) expanded up to pnom = 0.91 ± 0.05 MPa obtained in
water bath conditions.
the cutting process, but this can be disregarded by checking
that Cut 1 and Cut 2 caused indeed a slight decrease instead
of an increase of , as it can be seen in Table III, where  di-
minishes from 24.91 ± 0.03 mm, for the intact stent, to 24.66
± 0.04 mm, for the stent with two cuts. Our hypothesis is
that the natural path followed by the current induced along
the stent is truncated and the current is therefore compelled
to take another way larger than the original, which results in
a downshift of the resonant frequencies. In any case, MWS
is only able to provide signs of presence of Type I and Type
II fractures and not a quantitative assessment of the precise
place where fractures have occurred.
FIG. 11. Relation between the first resonant frequencies obtained experi-
mentally for the 30 MDS plus 27 MES stents measured in water (f ′1) and in
open air (f1) conditions. The solid line represents the least squares fit per-
formed on the f ′1(f1) data using Eq. (6). The dashed line represents the theo-
retical relation obtained from Eq. (5).
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TABLE IV. Results of the f1() = A/ + B fits obtained from each f1() data
set presented in Figs. 5(a) and 5(b). From left to right, columns indicate stent
model, nominal size (dnom), regression coefficients (A, B, r2), and scaling
factor (a). Because only two stents were available for the dnom = 3.00 mm
MDS and dnom = 2.75 mm MES families, the values provided for these stents
are just an interpolation and therefore lack error propagation analysis.
dnom A B
Model (mm) (GHz mm) (GHz) r2 a
2.25 54.2 ± 1.4 0.53 ± 0.13 0.9986 2.76 ± 0.07
2.50 49.2 ± 1.9 0.70 ± 0.12 0.993 3.08 ± 0.12
2.75 51.3 ± 1.8 0.44 ± 0.12 0.996 2.92 ± 0.10
MDS 3.00 58 1.2 . . . 2.6
3.50 75 ± 9 0.1 ± 0.5 0.95 2.0 ± 0.2
4.00 67.7 ± 1.1 0.93 ± 0.10 0.9989 2.22 ± 0.04
4.50 69.2 ± 0.7 0.79 ± 0.05 0.9995 2.17 ± 0.02
2.25 50 ± 2 0.68 ± 0.12 0.994 2.99 ± 0.12
2.50 49.9 ± 1.3 0.64 ± 0.07 0.997 3.00 ± 0.08
2.75 48 0.7 . . . 3.1
MES 3.00 60 ± 3 0.94 ± 0.19 0.98 2.51 ± 0.14
3.50 77 ± 6 0.0 ± 0.4 0.97 1.96 ± 0.14
4.00 70.5 ± 1.4 0.89 ± 0.07 0.998 2.13 ± 0.04
Figure 7(c) shows that in a Type III fracture the charac-
teristic f1 resonance of the unaltered stent (f 0ABC1 = 2.58
± 0.15 GHz) disappears and two new f1 modes occur at
higher frequencies, one for each emerging segment (f 3AB1
= 3.08 ± 0.12 GHz and f 3C1 = 4.53 ± 0.19 GHz). From
these new frequencies and using the f1() fit parameters
obtained for the dnom = 2.75 mm MDS stent family,
we can estimate via Eq. (4) the corresponding
lengths of such new segments, MWS (fifth column in
Table III). Similarly, Fig. 7(e) shows that after applying
Cut 4 on segment AB, its corresponding resonance splits
again in two new f1 modes of even higher frequencies (f 4A1
= 7.3 ± 0.3 GHz and f 4B1 = 5.7 ± 0.2 GHz). Notice how
the resonance for segment C remains unchanged (f 4C1
= 4.6 ± 0.2 GHz). Although MWS values are not compatible
with those obtained from direct measurement using a digital
caliper (fourth column in Table III), we demonstrate here that
a rough quantitative assessment of the length of each segment
is possible. Moreover, the presence of Type III or Type IV
fractures can be simply reported from a qualitative inspection
of the A(f, ϕ) diagrams provided by MWS.
4.C. Recoil tests
Results obtained in recoil tests are more subtle than those
achieved in fracture tests. On the one hand, the link between
the recoil experienced by a stent and its characteristic resonant
frequencies is rather indirect. Recoil results in a slight rise of
the resonant frequencies only if it involves reduction of the
stent length. In other words, if a certain recoil process main-
tains the original stent length, it should not modify the shape
of the corresponding A(f, ϕ) diagram and therefore would not
be detected by MWS. In any case, in other stents submitted
to the same test, the link between longitudinal shrinkage and
recoil seems to be a common feature. On the other hand, the
fact that f2(r) increases faster than f1(r) (see Fig. 9) is in accor-
dance with the linear dependence of fn on the resonant mode
n as it appears in Eq. (3).
More complex situations, such as partial recoil affecting
just a segment of the stent length, should also be detectable by
means of MWS, but only if the associated overall shortening
is enough to reshape the corresponding A(f, ϕ) diagram. For
a given recoil-related shrinkage, the shorter the stent is, the
more significant the corresponding rise of the resonant fre-
quency will be. This can be understood taking into account
the characteristic 1/ behavior of the stent resonant frequen-
cies, since fn() varies faster for low  values than for high
values [see for instance f1() in Fig. 5]. Nonetheless, MWS
cannot give a hint of the precise place where this nonuniform
recoil would occur.
4.D. Microwave resonance in a water phantom
The main characteristic that can be noticed in Fig. 10 is
that the resonance that appears in the A(f, ϕ) diagram (f ′1
= 0.479 ± 0.007 GHz) is shifted 1 order of magnitude down
with respect to the one obtained for the same stent in open
air (f1 = 4.1 ± 0.4 GHz). Notwithstanding, the resonances of
the shortest stents usually appear quite blurry when compared
with those of the largest ones, and they may be difficult to
detect. Additionally, none of the A(f, ϕ) diagrams acquired
provides traces of the second resonant modes predicted by
Eq. (3).
In order to check if the downshift mentioned before is in
line with theoretical expectations, we can use Eq. (3) to obtain
a general relation linking the frequency values in two dielec-
tric media:
f ′n = fn
√
rμr
′rμ′r
. (5)
Assuming air (r ≈ 1, μr ≈ 1) and water (′r ≈ 78, μ′r ≈ 1)
as initial and final medium, respectively, and considering that
the parameters for water are practically constant between
0.1 and 1.0 GHz,61 the relation f ′n ≈ fn/
√
78 should hold
theoretically.
The following least squares fit60 was then performed on the
f ′1(f1) data set shown in Fig. 11:
f ′1(f1) = A′f1 + B ′, (6)
where A′ = 0.113 ± 0.004 and B′ = −0.017 ± 0.016 GHz are
the values obtained for the fitting parameters. The correspond-
ing fit (solid line) as well as the theoretical f ′1(f1) dependence
predicted (dashed line) are depicted in Fig. 11 together with
the experimental data. Although the points in this figure are
somewhat scattered, the fit provides a good agreement with
the theoretical line (r2 = 0.95). Moreover, implicit in this ac-
cordance is the fact that the f ′1 values in water do also respect
the characteristic 1/ law followed by the corresponding f1
values in open air (Fig. 5).
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4.E. Final considerations
The experiments described in this paper are only in-
tended to establish properties of cardiovascular stents, and the
experimental setups used may not be representative of fu-
ture equipment to be used in clinical practice. Our setups
are conceptually derived from the ones used in measurements
done for radar target characterization,69, 70 where antennas are
placed in a far field regime.67 As a result, the receiving an-
tenna gathers a significant amount of stray signals besides the
ones scattered by the stent. In a clinical environment these
stray signals would be predominantly produced by scattering
in surrounding tissues and bones and may be strong enough
to mask the signal scattered by the stent. We foresee two pos-
sible alternatives to circumvent this.
The first one would consist in using near-field probes in-
stead of antennas, so that the microwave electric and magnetic
fields would be spatially confined to a small region around
the stent. The second alternative would consist in the usage
of modern microwave imaging techniques.71, 72 These tech-
niques are capable of resolving spatially the scattering pro-
duced at different points of the scanned volume, and could
be used to isolate the scattering produced by the stent from
that produced by surrounding tissues and bones. This capac-
ity is limited by the size of the resolution bins (voxels) of the
imaging technique, which depends on the wavelength in the
medium and the imaging algorithm used. While most of these
techniques use single frequency illumination, some broad-
band alternatives have been developed in recent years (see
Ref. 72 and references therein). Hence, these imaging tech-
niques could be used to evaluate the frequency response of the
scattered fields at the voxel(s) containing the stent to monitor
its structural integrity. In other words, our work shows that
these imaging techniques do not need to achieve an imag-
ing resolution capable of distinguishing the features to be de-
tected (fracture, recoil, shortening, etc.), as long as they cover
a frequency spectrum which is wide enough to detect the fre-
quency shifts provided by these features, either at their funda-
mental frequency or at one of its higher-order resonances.
Any of the two alternatives above would have to cope
with the signal fluctuation due to physiological motion such
as breath or heartbeat.73 To achieve this, a clinical apparatus
should use short acquisition times for the elemental measure-
ment events. Multiple measurement events may then be av-
eraged to improve the signal to noise ratio provided that the
measurements are synchronized with the heart rate.74
5. CONCLUSION
We have proved experimentally that metallic coronary
stents of millimeter size exhibit characteristic resonant fre-
quencies in their open air microwave scattering spectra. The
presence of such resonances could be understood using a sim-
ple theoretical model based on dipole antennas. We have also
tested the ability of our approach for the detection of stent
structural distortions. Microwave spectrometry provides signs
of presence of stent fractures ranging from Type I to Type
IV. Despite achieving only a qualitative assessment for Type
I and Type II fractures, a quantitative evaluation of Type III
and Type IV fractures is feasible. The method appears less
effective detecting stent recoil, but its quantitative evaluation
seems also possible if the diametrical shrinkage involves lon-
gitudinal shortening. Finally, preliminary tests using a water-
based phantom to simulate tissue have been performed. In
addition to observing the resonant frequencies of stents sub-
merged within the phantom, the results are in fair agreement
with theoretical estimates.
All this encourages to continue investigating, but much re-
mains to be done. In the first place, experiments should go
on by reproducing fracture and recoil test results in a more
reliable physiological phantom, and by extending the work
using ex vivo and in vivo trials in animal models. Moreover,
there is work pending in regard to the study of more com-
plex geometrical distortions, such as Type V fractures and
nonuniform recoil, as well as to the investigation of recently
observed failure modes in coronary stents, such as longitudi-
nal compression or postdeployment shortening.75, 76 Finally,
in the frequency range where we expect to find resonances in
implanted stents (0.2–2.0 GHz), the values of relative permit-
tivity for blood and smooth muscle cells (the major compo-
nent in typical neointimal hyperplasia) are different enough77
as to provoke a frequency shift in the stent resonances. This
would mean that the presence of restenosis could be poten-
tially detected by MWS. We are focusing efforts on these
prospects, because we understand restenosis as the ultimate
goal MWS should address.
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